Author Correction: PI3K/AKT activation induces PTEN ubiquitination and destabilization accelerating tumourigenesis (Nature Communications, (2015), 6, 1, (7769), 10.1038/ncomms8769);PI3K/AKT activation induces PTEN ubiquitination and destabilization accelerating tumourigenesis

Nature Communications

Volumn 6, Issue , 2015, Pages

  Lee, Min Sik ^a   Jeong, Man Hyung ^a   Lee, Hyun Woo ^b   Han, Hyun Ji ^a   Ko, Aram ^a   Hewitt, Stephen M ^c   Kim, Jae Hoon ^b,d   Chun, Kyung Hee ^b   Chung, Joon Yong ^c   Lee, Cheolju ^e   Cho, Hanbyoul ^b,d   Song, Jaewhan ^a  

^a Yonsei University   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

^c NATIONAL CANCER INSTITUTE   (United States)

^d Yonsei University College of Medicine   (South Korea)

^e Korea Institute of Science and Technology   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

MKRN1; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE B; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG; EGFR PROTEIN, HUMAN; EPIDERMAL GROWTH FACTOR RECEPTOR; MAKORIN RING FINGER PROTEIN 1; MTOR PROTEIN, HUMAN; NERVE PROTEIN; PHOSPHOPROTEIN; PTEN PROTEIN, HUMAN; RIBONUCLEOPROTEIN; TARGET OF RAPAMYCIN KINASE;

ENZYME ACTIVITY; PHYSIOLOGICAL RESPONSE; PROTEIN; SIGNAL; TENSION; TUMOR;

ARTICLE; CARCINOGENESIS; CARCINOGENICITY; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; PROTEIN EXPRESSION; SURVIVAL RATE; TUMOR XENOGRAFT; UBIQUITINATION; UTERINE CERVIX CANCER; ADENOCARCINOMA; CARCINOMA; CELL MOTION; FEEDBACK SYSTEM; GENE EXPRESSION REGULATION; GENETICS; HELA CELL LINE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; METABOLISM; MUTATION; PATHOLOGY; PHOSPHORYLATION; PROGNOSIS; PROTEIN PROCESSING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA; TUMOR CELL LINE; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX TUMOR;

ADENOCARCINOMA; CARCINOGENESIS; CARCINOMA; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL MOVEMENT; CERVICAL INTRAEPITHELIAL NEOPLASIA; FEEDBACK, PHYSIOLOGICAL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HELA CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; IN VITRO TECHNIQUES; MUTATION; NERVE TISSUE PROTEINS; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHOPROTEINS; PHOSPHORYLATION; PROGNOSIS; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTO-ONCOGENE PROTEINS C-AKT; PTEN PHOSPHOHYDROLASE; RECEPTOR, EPIDERMAL GROWTH FACTOR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RIBONUCLEOPROTEINS; TOR SERINE-THREONINE KINASES; UBIQUITINATION; UTERINE CERVICAL NEOPLASMS;

EID: 84937553660     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/s41467-020-20178-0     Document Type: Erratum

References (41)

1. Li, J. et al. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 275, 1943-1947 (1997).
2. Steck, P. A. et al. Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat. Genet. 15, 356-362 (1997).
3. Guldberg, P. et al. Disruption of the MMAC1/PTEN gene by deletion or mutation is a frequent event in malignant melanoma. Cancer Res. 57, 3660-3663 (1997).
4. Di Cristofano, A., Pesce, B., Cordon-Cardo, C. & Pandolfi, P. P. Pten is essential for embryonic development and tumour suppression. Nat. Genet. 19, 348-355 (1998).
5. Hopkins, B. D., Hodakoski, C., Barrows, D., Mense, S. M. & Parsons, R. E. PTEN function: the long and the short of it. Trends Biochem. Sci. 39, 183-190 (2014).
6. Cully, M., You, H., Levine, A. J. & Mak, T. W. Beyond PTEN mutations: the PI3K pathway as an integrator of multiple inputs during tumorigenesis. Nat. Rev. Cancer 6, 184-192 (2006).
7. Song, M. S., Salmena, L. & Pandolfi, P. P. The functions and regulation of the PTEN tumour suppressor. Nat. Rev. Mol. Cell Biol. 13, 283-296 (2012).
8. Blumenthal, G. M. & Dennis, P. A. PTEN hamartoma tumor syndromes. Eur. J. Hum. Genet. 16, 1289-1300 (2008).
9. Liaw, D. et al. Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nat. Genet. 16, 64-67 (1997).
10. Marsh, D. J. et al. Germline mutations in PTEN are present in Bannayan-Zonana syndrome. Nat. Genet. 16, 333-334 (1997).
11. Ojesina, A. I. et al. Landscape of genomic alterations in cervical carcinomas. Nature 506, 371-375 (2014).
12. Wang, X. & Jiang, X. Post-translational regulation of PTEN. Oncogene 27, 5454-5463 (2008).
13. Fata, J. E., Debnath, S., Jenkins, Jr. E. C. & Fournier, M. V. Nongenomic mechanisms of PTEN regulation. Int. J. Cell Biol. 2012, 379685 (2012).
14. Trotman, L. C. et al. Ubiquitination regulates PTEN nuclear import and tumor suppression. Cell 128, 141-156 (2007).
15. Shi, Y., Paluch, B. E., Wang, X. & Jiang, X. PTEN at a glance. J. Cell Sci. 125, 4687-4692 (2012).
16. Wang, X. et al. NEDD4-1 is a proto-oncogenic ubiquitin ligase for PTEN. Cell 128, 129-139 (2007).
17. Maddika, S. et al. WWP2 is an E3 ubiquitin ligase for PTEN. Nat. Cell Biol. 13, 728-733 (2011).
18. Van Themsche, C., Leblanc, V., Parent, S. & Asselin, E. X-linked inhibitor of apoptosis protein (XIAP) regulates PTEN ubiquitination, content, and compartmentalization. J. Biol. Chem. 284, 20462-20466 (2009).
19. Ahmed, S. F. et al. The chaperone-assisted E3 ligase C terminus of Hsc70-interacting protein (CHIP) targets PTEN for proteasomal degradation. J. Biol. Chem. 287, 15996-16006 (2012).
20. Zhang, J. et al. Deubiquitylation and stabilization of PTEN by USP13. Nat. Cell Biol. 15, 1486-1494 (2013).
21. Li, G. et al. SPOP promotes tumorigenesis by acting as a key regulatory hub in kidney cancer. Cancer Cell. 25, 455-468 (2014).
22. Ko, A. et al. MKRN1 induces degradation of West Nile virus capsid protein by functioning as an E3 ligase. J. Virol. 84, 426-436 (2010).
23. Lee, E. W. et al. Differential regulation of p53 and p21 by MKRN1 E3 ligase controls cell cycle arrest and apoptosis. EMBO J. 28, 2100-2113 (2009).
24. Lee, E. W. et al. Ubiquitination and degradation of the FADD adaptor protein regulate death receptor-mediated apoptosis and necroptosis. Nat. Commun. 3, 978 (2012).
25. Ko, A. et al. Acceleration of gastric tumorigenesis through MKRN1-mediated posttranslational regulation of p14ARF. J. Natl. Cancer Inst. 104, 1660-1672 (2012).
26. Wu, W. et al. Zinc-induced PTEN protein degradation through the proteasome pathway in human airway epithelial cells. J. Biol. Chem. 278, 28258-28263 (2003).
27. Zeng, T. et al. Impeded nedd4-1-mediated ras degradation underlies ras-driven tumorigenesis. Cell Rep. 7, 871-882 (2014).
28. Samuels, Y. et al. High frequency of mutations of the PIK3CA gene in human cancers. Science 304, 554 (2004).
29. Samuels, Y. et al. Mutant PIK3CA promotes cell growth and invasion of human cancer cells. Cancer Cell 7, 561-573 (2005).
30. Suzuki, C. et al. ANLN plays a critical role in human lung carcinogenesis through the activation of RHOA and by involvement in the phosphoinositide 3-kinase/AKT pathway. Cancer Res. 65, 11314-11325 (2005).
31. Obata, T. et al. Peptide and protein library screening defines optimal substrate motifs for AKT/PKB. J. Biol. Chem. 275, 36108-36115 (2000).
32. Burri, N. et al. Methylation silencing and mutations of the p14ARF and p16INK4a genes in colon cancer. Lab. Invest. 81, 217-229 (2001).
33. Chalhoub, N. & Baker, S. J. PTEN and the PI3-kinase pathway in cancer. Annu. Rev. Pathol. 4, 127-150 (2009).
34. Hollander, M. C., Blumenthal, G. M. & Dennis, P. A. PTEN loss in the continuum of common cancers, rare syndromes and mouse models. Nat. Rev. Cancer 11, 289-301 (2011).
35. Chen, T. M., Pecoraro, G. & Defendi, V. Genetic analysis of in vitro progression of human papillomavirus-transfected human cervical cells. Cancer Res. 53, 1167-1171 (1993).
36. Dalstein, V. et al. Persistence and load of high-risk HPV are predictors for development of high-grade cervical lesions: a longitudinal French cohort study. Int. J. Cancer 106, 396-403 (2003).
37. Kang, S. et al. Inverse correlation between RASSF1A hypermethylation, KRAS and BRAF mutations in cervical adenocarcinoma. Gynecol. Oncol. 105, 662-666 (2007).
38. Camus, S., Higgins, M., Lane, D. P. & Lain, S. Differences in the ubiquitination of p53 by Mdm2 and the HPV protein E6. FEBS Lett. 536, 220-224 (2003).
39. Yang, M. R. et al. West Nile virus capsid protein induces p53-mediated apoptosis via the sequestration of HDM2 to the nucleolus. Cell Microbiol. 10, 165-176 (2008).
40. Chung et al. The expression of phospho-AKT, phospho-mTOR, and PTEN in extrahepatic cholangiocarcinoma. Clin Cancer Res. 15, 660-667 (2009).
41. Andersen, M. H. et al. Immunogenicity of constitutively active V599EBRaf. Cancer Res. 64, 5456-5460 (2004).